옵션 체인은 다양한 행사가격과 만기일에 대한 Gyre Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Gyre Therapeutics에 대한 시장 심리를 평가합니다..

Gyre Therapeutics (NASDAQ:GYRE) 주식, 옵션 체인

Gyre Therapeutics

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics Inc

<a href="https://www.benzinga.com/etfs">Exchange-traded funds</a> with significant exposure to Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could be in for a rough ride, not due to production setbacks or margin squeeze, but thanks to a new set of political fireworks between <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">Elon Musk and Donald Trump</a>.
On Tuesday, <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45795638/tesla-stock-slumps-amid-political-turmoil-whats-going-on">TSLA stock plummeted</a> as President Trump publicly criticized Musk, stating he was &#8220;disappointed&#8221; with the Tesla CEO&#8217;s &#8220;furious bashing&#8221; of the tax legislation. The remark came on the heels of reports that Musk, in behind-the-scenes talks, showed intense opposition to the bill&#8217;s incentives for clean energy, which he feels benefit union-supported automakers at Tesla&#8217;s expense. On Thursday, the Tesla stock is down a sharp 15%.
While Musk has never hesitated to court controversy, the new spat adds one more level of risk for investors, especially those who are exposed through ETFs that hold Tesla as a strategic holding.
Also Read: <a href="https://www.benzinga.com/news/politics/25/06/45795080/whatever-you-think-of-elon-musk-you-must-support-his-fight-against-the-big-beautiful-bill-says-black-swan-author-nassim-taleb">&#8216;Whatever You Think Of Elon Musk, You Must Support His Fight Against The Big Beautiful Bill,&#8217; Says &#8216;Black Swan&#8217; Author Nassim Taleb</a>
<h2 class="wp-block-heading">ETFs In The Crosshairs</h2>
Tesla is still a major contributor to a number of actively and passively managed ETFs, particularly those that concentrate on innovation, EVs, and clean energy. Some of the most exposed:
ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>) – Tesla is the single largest holding, frequently making up 12% or more of the portfolio.
iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>) – Tesla is frequently in the top five, but it has cut its weightage to 3.5% in the last rejig.
KraneShares Electric Vehicles and Future Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KARS#NYSE">KARS</a>) – TSLA is prominent, at almost 4% weightage.
They&#8217;ve gone through volatility already with Tesla&#8217;s stock price, which fell almost 20% through the past five trading days. But political tension adds a wilder variable, one that&#8217;s difficult to price into models and more difficult to hedge in a diversified basket.
<h2 class="wp-block-heading">Passive Exposure, Active Headaches</h2>
For individual investors who are not monitoring every political headline, indirect exposure to these risks through ETFs can be a surprise in store.
This is the classic example of political risk spilling over into passive portfolios. When Tesla catches a cold, ARKK gets it, and when Musk gets involved in a political fight, it&#8217;s the ETF investors who will need a flu shot.
<h2 class="wp-block-heading">Looking Ahead</h2>
In the near term, ETF issuers won&#8217;t rebalance on political noise alone. But ongoing stress about Tesla&#8217;s regulatory and political positioning might impact flows.
For investors in ETFs, the takeaway can be less about Musk himself and more learning what&#8217;s driving their portfolios from beneath the hood. Because sometimes, earnings or interest rates aren&#8217;t driving your fund, it&#8217;s Elon Musk, a tweet from some social media account, and a news headline with Donald Trump&#8217;s name on it.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/06/45801050/crash-proof-investing-new-innovator-etf-promises-downside-buffer">Crash-Proof Investing? New Innovator ETF Promises Downside Buffer</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Tech

ETFs

ARKK

IDRV

KARS

TSLA

Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire

News

Offerings

Trump Media & Technology Files For Primary Mixed Shelf Offering Of Up To $12B

Xtract One Technologies (TSX:<a class="ticker" href="https://www.benzinga.com/stock/XTRA#TSX">XTRA</a>) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $3.47 million in sales this quarter. This is a 26.00 percent decrease over sales of $4.68 million the same period last year.

Earnings

TSX:XTRA

Xtract One Technologies Q3 EPS $(0.02) Down From $(0.01) YoY, Sales $3.47M Down From $4.68M YoY

Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: <a href="https://www.benzinga.com/stock/djt#Nasdaq,%20NYSE%20Texas">DJT</a>) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has filed a registration statement on form S-3 ("Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") related to debt and equity subscription agreements recently entered into with approximately fifty investors that yielded approximately $2.3 billion in total proceeds—one of the largest Bitcoin treasury deals for a public company. The proceeds will be used for the Company's creation of a Bitcoin treasury and for general corporate purposes.
In accordance with registration obligations in the previously-disclosed agreements, the Registration Statement seeks to register for resale by the investors approximately 56 million shares of equity and 29 million shares underlying convertible notes.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Trump Media Files SEC Registration Statement To Enable Resale Of Shares From $2.3B Bitcoin-Focused Financing Deal With 50 Investors

Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, domain expertise, and strategic partnerships&nbsp;&nbsp;
NEW YORK, June 5, 2025 /PRNewswire/ --&nbsp;Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>), a global advanced technology services and solutions company, today announced it has acquired XponentL Data, a data products and artificial intelligence (AI) solutions provider. XponentL brings differentiated domain-led data strategy, design, and engineering capabilities; deep industry experience; and strategic partnerships. This acquisition builds on Genpact's pivot to data, AI, and other advanced technologies, further enhancing Genpact's ability to help clients across the lifecycle of AI transformation, from strategy through implementation.

Genpact Acquires XponentL Data; Financial Details Of The Transaction Were Not Disclosed.

Management

NAVI

Navient Elects Edward Bramson Chair Of The Board Of Directors

IAC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) ("IAC") announced today that its wholly owned subsidiary, Dotdash Meredith Inc. ("DDM"), has agreed to sell $400 million aggregate principal amount of 7.625% senior secured notes due 2032 (the "Notes") in a private offering (the "Offering").&nbsp; The Notes will bear interest at an interest rate of 7.625% per annum and will be issued at 100.00% of their face value.&nbsp; DDM's obligations under the Notes will be guaranteed on a senior secured basis by certain of DDM's subsidiaries.
DDM intends to use the proceeds of the offering, together with the borrowings under DDM's new $700.0 million term loan B facility and cash on hand, to repay all of the indebtedness outstanding under DDM's existing $1.18 billion term loan B-1 facility and to pay related fees and expenses.&nbsp; The closings of each of the Offering and new term loan B facility are expected to occur on or about June 16, 2025, each subject to the satisfaction of customary closing conditions.

IAC's Dotdash Meredith, Has Agreed To Sell $400M Aggregate Principal Amount Of 7.625% Senior Secured Notes Due 2032

Air T, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRT#NASDAQ">AIRT</a>) announced on June 2nd the successful renegotiation of a key financing agreement involving its wholly owned subsidiary, AAM 24-1, LLC.
The updated agreement, reached with the Company's existing institutional investors, grows the transaction from $30,000,000 to $100,000,000, extends repayment timelines and increases financial flexibility. These changes support Air T's long-term capital foundation while maintaining alignment with its strategic objectives and commitment to growth.

Financing

AIRT

Air T Expands Key Financing Deal From $30M To $100M, Boosting Flexibility And Supporting Long-Term Growth Strategy

<h3>Gainers</h3>
<ul>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares moved upwards by 10.5% to $0.38 during Thursday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 10.15% to $7.7. The market value of their outstanding shares is at $30.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock moved upwards by 7.85% to $2.06. The market value of their outstanding shares is at $40.5 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock rose 6.17% to $1.72. The company's market cap stands at $492.2 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) shares increased by 5.94% to $2.85. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) shares rose 5.55% to $0.38. The company's market cap stands at $10.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock decreased by 22.9% to $255.09 during Thursday's after-market session. The company's market cap stands at $31.9 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares declined by 13.73% to $1.32. The market value of their outstanding shares is at $21.6 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares decreased by 11.88% to $3.19. The market value of their outstanding shares is at $889.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SORA#NASDAQ">SORA</a>) stock decreased by 9.42% to $6.35. The market value of their outstanding shares is at $157.8 million. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) shares decreased by 6.3% to $12.05. The company's market cap stands at $230.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares fell 5.53% to $0.34. The market value of their outstanding shares is at $24.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

JDZG

LULU

NWTN

RENT

SORA

WOOF

ZUMZ

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock rose 41.5% to $2.15 during Thursday's after-market session. The market value of their outstanding shares is at $3.2 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) shares moved upwards by 30.86% to $0.26. The company's market cap stands at $16.7 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares increased by 28.97% to $4.05. The company's market cap stands at $11.6 million. </li>
<li>Pediatrix Medical Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) shares moved upwards by 8.47% to $15.1. The company's market cap stands at $1.2 billion. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) shares increased by 7.27% to $0.57. The company's market cap stands at $19.0 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock rose 6.86% to $1.09. The company's market cap stands at $144.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares declined by 18.7% to $20.0 during Thursday's after-market session. The company's market cap stands at $534.2 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) shares decreased by 10.12% to $3.2. The market value of their outstanding shares is at $83.4 million. </li>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares decreased by 9.44% to $8.06. The market value of their outstanding shares is at $116.8 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock fell 8.15% to $3.86. The company's market cap stands at $58.7 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares decreased by 7.83% to $2.12. The market value of their outstanding shares is at $1.5 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares declined by 7.7% to $3.0. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BJDX

EYEN

GLYC

LIMN

NIVF

PTHL

RANI

RAPT

SCNI

SNTI

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares moved upwards by 14.1% to $1.86 during Thursday's after-market session. The company's market cap stands at $10.2 million. </li>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares increased by 11.5% to $3.49. The company's market cap stands at $145.0 million. </li>
<li>EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) shares moved upwards by 8.33% to $8.84. The market value of their outstanding shares is at $24.9 million. The company's, Q1 earnings came out today. </li>
<li>Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) stock moved upwards by 7.19% to $18.32. The company's market cap stands at $865.2 million. The company's, Q2 earnings came out today. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) stock increased by 7.12% to $1.03. The company's market cap stands at $19.9 million. </li>
<li>Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) stock rose 6.44% to $1.57. The market value of their outstanding shares is at $28.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock decreased by 12.3% to $6.2 during Thursday's after-market session. The company's market cap stands at $328.9 million. The company's, Q2 earnings came out today. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares declined by 11.96% to $0.5. The company's market cap stands at $15.6 million. </li>
<li>Linkers Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKS#NASDAQ">LNKS</a>) stock fell 6.89% to $0.59. The company's market cap stands at $7.9 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock decreased by 6.72% to $0.58. The company's market cap stands at $46.4 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares fell 6.71% to $0.63. The market value of their outstanding shares is at $10.9 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 6.09% to $0.23. The company's market cap stands at $52.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBCP

EDRY

LGCL

LNKS

LNZA

MNTS

SIDU

SPCE

ZBAI

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock moved upwards by 9.9% to $1.77 during Thursday's after-market session. The company's market cap stands at $3.2 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares increased by 4.97% to $4.22. The company's market cap stands at $10.0 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares moved upwards by 4.95% to $7.2. The company's market cap stands at $120.1 million. </li>
<li>Expensify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) shares rose 4.82% to $2.39. The market value of their outstanding shares is at $220.8 million. </li>
<li>SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) shares moved upwards by 4.62% to $0.97. The market value of their outstanding shares is at $182.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock moved upwards by 4.42% to $1.18. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) stock declined by 16.0% to $78.05 during Thursday's after-market session. The market value of their outstanding shares is at $15.8 billion. As per the news, the Q1 earnings report came out today. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock decreased by 14.63% to $4.44. The market value of their outstanding shares is at $22.7 million. </li>
<li>ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) shares declined by 12.76% to $99.94. The market value of their outstanding shares is at $8.9 billion. As per the press release, Q1 earnings came out today. </li>
<li>Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares declined by 11.54% to $41.8. The company's market cap stands at $23.7 billion. The company's, Q1 earnings came out today. </li>
<li>Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) stock fell 9.06% to $32.84. The company's market cap stands at $3.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>BitMine Immersion Technologies, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock fell 8.91% to $7.06. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

ASTI

BMNR

BRZE

DOCU

EXFY

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

SMRT

SVRE

TTAN

12 Information Technology Stocks Moving In Thursday's After-Market Session

VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) ("VEON"), a global digital operator, announces the public filing of a registration statement on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") in connection with the listing of Kyivstar Group Ltd. ("Kyivstar Group"), the parent company of Ukraine's leading digital operator JSC Kyivstar, on the Nasdaq Stock Market LLC ("Nasdaq").
This filing represents a milestone in VEON's plans to list Kyivstar Group on Nasdaq following the anticipated completion of a business combination with Cohen Circle Acquisition Corp. I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCIR#NASDAQ">CCIR</a>) ("Cohen Circle") that was announced on March 18, 2025. At the closing of the transaction, the business combination will result in the listing of Kyivstar Group's common shares and warrants on Nasdaq under the ticker symbols "KYIV" and "KYIVW," respectfully, as the only pure-play Ukrainian investment opportunity on U.S. stock markets.

CCIR

VEON

VEON Files Registration Statement With SEC To List Kyivstar Group On Nasdaq Following Planned Merger With Cohen Circle Under Tickers "KYIV"

Saputo (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SAP#TSX">SAP</a>) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.34 by 11.76 percent. This is a 18.92 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $4.75 billion which beat the analyst consensus estimate of $4.74 billion by 0.27 percent. This is a 4.58 percent increase over sales of $4.54 billion the same period last year.

Earnings Beats

Earnings Misses

TSX:SAP

Saputo Q4 Adj. EPS $0.30 Misses $0.34 Estimate, Sales $4.75B Beat $4.74B Estimate

Vail Resorts Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) reported financial results for the third quarter on Thursday after the bell. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/06/n45802286/vail-resorts-reports-fiscal-2025-third-quarter-results-provides-updated-fiscal-2025-guidance-and-p">from the print</a>.
Q3 Earnings: Vail Resorts reported third-quarter revenue of $1.29 billion, narrowly missing estimates of $1.3 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported third-quarter earnings of $10.54 per share, beating estimates of $10.12 per share. 
Total revenue was up 1% year-over-year. Pass product sales&nbsp;for the upcoming 2025/2026 North American ski season decreased approximately&nbsp;1%&nbsp;in units, but increased approximately&nbsp;2%&nbsp;in sales dollars.
Vail Resorts&#8217; board declared a quarterly cash dividend of $2.22 per share, payable on July 9 to shareholders of record as of June 24. 
&#8220;Results in the quarter reflect the stability provided by our season pass program as Resort net revenue, excluding Crans-Montana, remained consistent with the prior year even as visitation declined 7%,&#8221; said Rob Katz, CEO of Vail Resorts.
&#8220;Our performance throughout the 2024/2025 North American ski season reflects the strength of our advance commitment strategy, strong destination guest spending, and the impact of our resource efficiency transformation plan.&#8221;
Vail announced at the end of May that Katz was taking over as CEO for Kirsten Lynch, who decided to step down from the role. 
Vail said it expects to achieve $100 million in annualized cost efficiencies by the end of fiscal 2026 due to the company&#8217;s two-year resource efficiency transformation plan, announced in September 2024.
Outlook: The company expects fiscal 2025 net income attributable to Vail Resorts to be between&nbsp;$264 million&nbsp;and&nbsp;$298 million, and Resort Reported EBITDA for fiscal 2025 to be between&nbsp;$831 million&nbsp;and&nbsp;$851 million.&nbsp;
&#8220;The guidance reflects the lower than expected lift ticket visitation in the spring period that was partially mitigated by the Company&#8217;s focus on its resource efficiency transformation plan and strong cost discipline,&#8221; the company said.
Vail Resorts executives will further discuss the quarter on a conference call set for 5 p.m. ET.
MTN Price Action:&nbsp;<a href="http://benzinga.com/quote/MTN" target="_blank" rel="noreferrer noopener">Vail Resorts shares</a>&nbsp;were down 1.04% in after-hours, trading at $153.33 at the time of publication Thursday, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45803051/docusign-stock-plummets-after-q1-earnings-report-details">DocuSign Stock Plummets After Q1 Earnings Report: Details</a></li>
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45803595/broadcom-q2-earnings-revenue-eps-beat-estimates-driven-by-robust-demand-for-ai-networking-company-sees-acceleration-in-ai-revenue-ahead">Broadcom Q2 Earnings: Revenue, EPS Beat Estimates Driven By &#8216;Robust Demand&#8217; For AI Networking, Company Sees Acceleration In AI Revenue Ahead</a></li>
</ul>
Photo: Tint Media/Shutterstock.

Guidance

Travel

Sports

After-Hours Center

Vail Resorts Stock Slides On Q3 Earnings, Company Targets $100 Million In Annualized Cost Efficiencies

Enghouse Systems (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ENGH#TSX">ENGH</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.37 by 35.14 percent. This is a 33.33 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $124.82 million which missed the analyst consensus estimate of $129.48 million by 3.60 percent. This is a 0.79 percent decrease over sales of $125.81 million the same period last year.

TSX:ENGH

Enghouse Systems Q2 EPS $0.24 Misses $0.37 Estimate, Sales $124.82M Miss $129.48M Estimate

In the current market session, Frontline Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) share price is at $18.13, after a 0.17% drop. Over the past month, the stock went up by 5.96%, but over the past year, it actually decreased by 30.93%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1749157220_0.png" alt="Past Year Chart" />

<h3>Comparing Frontline P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 76.1 in the Oil, Gas &amp; Consumable Fuels industry, Frontline Inc. has a lower P/E ratio of 11.57. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749157220_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

A Look Into Frontline Inc's Price Over Earnings

Northern Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) has outperformed the market over the past 5 years by 4.64% on an annualized basis producing an average annual return of 17.71%. Currently, Northern Oil &amp; Gas has a market capitalization of $2.74 billion. 
Buying $100 In NOG: If an investor had bought $100 of NOG stock 5 years ago, it would be worth $220.63 today based on a price of $27.80 for NOG at the time of writing.
<h3>Northern Oil &amp; Gas's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749157219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Northern Oil & Gas 5 Years Ago Would Be Worth Today

WIIM

TBH stock has given up its prior loss. Brag House Holdings shares were trading lower after the company announced it is working to file its delayed Q1 10-Q report.

Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) shares surged to a new all-time high of $469.65 on Thursday before closing up 0.82% at $467.68, despite no company-specific news. The rally comes as broader market trends continue to favor mega-cap tech stocks, especially those leading in artificial intelligence and cloud computing.
What To Know: A recent software spending survey by BofA Securities analyst Brad Sills <a href="https://www.benzinga.com/markets/large-cap/25/06/45755544/rising-ai-analytics-budgets-could-lift-microsoft-snowflake-datadog">signaled</a> modest declines in software growth expectations for 2025 and 2026, citing macroeconomic uncertainties. 
Still, spending is projected to grow nearly 10% annually, with data analytics, cloud communications and security remaining top priorities. Microsoft, Snowflake and Datadog are seen as key beneficiaries in analytics, security and cloud infrastructure.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/45800099/palantir-ceo-alex-karp-refutes-ridiculous-surveillance-reports-says-company-is-winning">Palantir CEO Alex Karp Refutes &#8216;Ridiculous&#8217; Surveillance Reports, Says Company Is &#8216;Winning&#8217;</a>
Meanwhile, strong corporate earnings are <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45758803/sp-500-q1-earnings-stun-again-the-street-with-broad-based-beats-double-digit-growth">fueling</a> bullish sentiment. Nearly 80% of S&amp;P 500 firms topped first-quarter expectations, delivering a 13.3% profit increase. Microsoft was among six of the Magnificent Seven to beat estimates, contributing to a collective $1.75 trillion market cap gain in May, the group's best month in years.
Analysts warn valuations are <a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45775924/david-mazza-on-mags-magnificent-may-the-breadth-of-the-rally-stood-out">stretched</a>, with Microsoft trading at a forward P/E near 27. But investors continue to reward firms with robust AI-driven growth and durable business models, positioning Microsoft as a leader in the next wave of tech innovation.
Read Also: <a href="https://www.benzinga.com/markets/market-summary/25/06/45798808/trump-announces-china-trade-talks-tesla-stock-slumps-whats-driving-markets-thursday">Trump Announces China Trade Talks, Tesla Stock Slumps: What&#8217;s Driving Markets Thursday?</a>
<h1 class="wp-block-heading">How To Buy MSFT Stock</h1>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Microsoft is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MSFT has a 52-week high of $469.65 and a 52-week low of $344.79.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45801194/why-analyst-sees-attractive-valuation-for-calvin-klein-parent-pvh-despite-noisy-q1#google_vignette" target="_blank" rel="noreferrer noopener">Why Analyst Sees Attractive Valuation For Calvin Klein Parent PVH Despite ‘Noisy' Q1</a></li>
</ul>
Image: Shutterstock

MSFT

Microsoft Hits Record High Amid Strong Tech Sector Momentum: What's Going On?

Press Releases

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Health Care

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology

Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications

Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Gyre Therapeutics' Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Comments

Gyre Therapeutics

Gyre Therapeutics (GYRE) 옵션

Gyre Therapeutics (NASDAQ:GYRE) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌